Sim&Cure

Montpellier, France · Founded 2013 · Privately Held (backing)

Developer of a patient-specific device designed to secure the treatment of a cerebral aneurysm. Sim&Cure is based in Montpellier, France and was founded in 2013. Its last reported valuation was $48.7 million in Nov 2025. It has raised $21.1 million.

Last reported valuation
$48.7M
Oct 2026
Priced at
—
Total raised
$21.1M
Last round
—

Who backs Sim&Cure?

13 investors
InvestorType
Elaia PartnersVenture capital
IRDI Capital InvestissementPE / buyout
SWEN Capital PartnersPE / buyout
SofilaroPE / buyout
Alexis Frentz—
Business & Innovation Center—
Club Holnest—
IT-Translation—
Languedoc Roussillon Incubation—
Montpellier Méditerranée Métropole—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Sim&Cure investors

13 investors are on record for Sim&Cure, including Elaia Partners, IRDI Capital Investissement, SWEN Capital Partners and Sofilaro.

Free account
More of Sim&Cure with a free account
  • ·The complete investor list: 13 names
  • ·Watch Sim&Cure: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like Sim&Cure. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View